Balk SP - Search Results

1

Transcriptional mediators of treatment resistance in lethal prostate cancer.

He MX, Cuoco MS, Crowdis J, Bosma-Moody A, Zhang Z, Bi K, Kanodia A, Su MJ, Ku SY, Garcia MM, Sweet AR, Rodman C, DelloStritto L, Silver R, Steinharter J, Shah P, Izar B, Walk NC, Burke KP, Bakouny Z, Tewari AK, Liu D, Camp SY, Vokes NI, Salari K, Park J, Vigneau S, Fong L, Russo JW, Yuan X, Balk SP, Beltran H, Rozenblatt-Rosen O, Regev A, Rotem A, Taplin ME, Van Allen EM. He MX, et al. Among authors: balk sp. Nat Med. 2021 Mar;27(3):426-433. doi: 10.1038/s41591-021-01244-6. Epub 2021 Mar 4. Nat Med. 2021. PMID: 33664492 Free PMC article.

2

Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer.

Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN, Balk SP. Taplin ME, et al. Among authors: balk sp. N Engl J Med. 1995 May 25;332(21):1393-8. doi: 10.1056/NEJM199505253322101. N Engl J Med. 1995. PMID: 7723794 Free article.

3

Treatment of metastatic prostate cancer. Lessons from the androgen receptor.

Bubley GJ, Balk SP. Bubley GJ, et al. Among authors: balk sp. Hematol Oncol Clin North Am. 1996 Jun;10(3):713-25. doi: 10.1016/s0889-8588(05)70363-4. Hematol Oncol Clin North Am. 1996. PMID: 8773507 Review.

4

Evidence against T-cell development in the adult human intestinal mucosa based upon lack of terminal deoxynucleotidyltransferase expression.

Taplin ME, Frantz ME, Canning C, Ritz J, Blumberg RS, Balk SP. Taplin ME, et al. Among authors: balk sp. Immunology. 1996 Mar;87(3):402-7. doi: 10.1046/j.1365-2567.1996.496571.x. Immunology. 1996. PMID: 8778025 Free PMC article.

5

High dose bicalutamide for androgen independent prostate cancer: effect of prior hormonal therapy.

Joyce R, Fenton MA, Rode P, Constantine M, Gaynes L, Kolvenbag G, DeWolf W, Balk S, Taplin ME, Bubley GJ. Joyce R, et al. J Urol. 1998 Jan;159(1):149-53. doi: 10.1016/s0022-5347(01)64039-4. J Urol. 1998. PMID: 9400459

6

Functional characterization of mutant androgen receptors from androgen-independent prostate cancer.

Fenton MA, Shuster TD, Fertig AM, Taplin ME, Kolvenbag G, Bubley GJ, Balk SP. Fenton MA, et al. Among authors: balk sp. Clin Cancer Res. 1997 Aug;3(8):1383-8. Clin Cancer Res. 1997. PMID: 9815822

7

Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist.

Taplin ME, Bubley GJ, Ko YJ, Small EJ, Upton M, Rajeshkumar B, Balk SP. Taplin ME, et al. Among authors: balk sp. Cancer Res. 1999 Jun 1;59(11):2511-5. Cancer Res. 1999. PMID: 10363963

8

SRY interacts with and negatively regulates androgen receptor transcriptional activity.

Yuan X, Lu ML, Li T, Balk SP. Yuan X, et al. Among authors: balk sp. J Biol Chem. 2001 Dec 7;276(49):46647-54. doi: 10.1074/jbc.M108404200. Epub 2001 Oct 3. J Biol Chem. 2001. PMID: 11585838 Free article.

9

A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4.

Amir AL, Barua M, McKnight NC, Cheng S, Yuan X, Balk SP. Amir AL, et al. Among authors: balk sp. J Biol Chem. 2003 Aug 15;278(33):30828-34. doi: 10.1074/jbc.M301208200. Epub 2003 Jun 10. J Biol Chem. 2003. PMID: 12799378 Free article.

10

Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence.

Taplin ME, Balk SP. Taplin ME, et al. Among authors: balk sp. J Cell Biochem. 2004 Feb 15;91(3):483-90. doi: 10.1002/jcb.10653. J Cell Biochem. 2004. PMID: 14755679 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

276 results

Search Page

Filters